The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. - Wikidata - wikimedia - TriplyDB

The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.

The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.

http://www.wikidata.org/entity/Q34286402

about

Corticosteroid implants for chronic non-infectious uveitis Emerging drugs for uveitis Involvement of B cells in non-infectious uveitis Medical management of uveitis - current trends Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.Epiretinal membranes in uveitic macular edema: effect on vision and response to therapy.Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.The transitioning from trials to extended follow-up studies.Epidemiology of epiretinal membrane in a large cohort of patients with uveitis.Success with single-agent immunosuppression for multifocal choroidopathies.Emerging role of antioxidants in the protection of uveitis complications.Juvenile idiopathic arthritis-associated uveitis.Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography Clinical trials in noninfectious uveitis Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients Vision-Related Quality of Life in Patients with Inactive HLA-B27-Associated-Spectrum Anterior Uveitis Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial Validation of a photographic vitreous haze grading technique for clinical trials in uveitis.Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Tr Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Foll Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography.Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study.Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.Morphometric spectral-domain optical coherence tomography features of epiretinal membrane correlate with visual acuity in patients with uveitis Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study The impact of macular edema on visual function in intermediate, posterior, and panuveitis.Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.Fundus image diagnostic agreement in uveitis utilizing free and open source software Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials.Morphological assessment of the retina in uveitis.Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial Trends in patterns of intermediate uveitis in a tertiary institution in Singapore.Road to remission: a comprehensive review of therapy in uveitis.Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye.

P2860

Q24186144-4685103A-F20D-4D0A-AA3A-4014D60CBB49 Q24630848-696DAA00-8B73-4098-B91C-47E7629F6CD4 Q26766611-537495E4-9A5A-4C53-8EBF-E9F00E5184D2 Q27003399-AE043CD0-9C8C-4AA9-9870-F25607548584 Q27693189-39CF23ED-CBC9-4512-85F1-3FDA59501B40 Q33765919-3E85E686-AE8A-4EDF-95D4-F55B04D1944E Q34258708-CFCE6071-A080-4205-8896-2D113CF22859 Q34498537-07447F0E-DE34-4F21-8C65-CD2DA6974F17 Q34616405-967992B8-D482-4F0C-BFAE-359B389A8F48 Q34623981-C7CBB77B-92C6-42A0-97B7-25818018430B Q34887046-729C2637-A318-4BB9-8661-D25861FD5803 Q34950552-CA6EA349-44DF-4195-8C0D-42E79A890959 Q35319079-2235FB85-6958-4C38-B8AA-A9DBFD1E2F86 Q35570770-6FC08BB3-25E7-40E3-8865-2627AE70C351 Q35681664-9100CC96-34D7-4AAB-91DD-BD7EDDA29C26 Q35699360-CAC56445-29BD-43E8-AE0D-84476B409AB7 Q35903956-1A1CE6E0-CE83-4D54-9E6E-4DAB7846F671 Q35921417-4E3404E0-47C6-4037-90CB-1A2489A6A06F Q36017096-0D513E7D-88BF-4AD5-872B-0395892997E4 Q36090279-FD2E7ED8-3F09-4EB5-8764-416EA84A1AA7 Q36090415-C23DBA1E-6827-4CA5-ADC2-C65DE76E236D Q36132907-9E22F674-DC56-43E8-BAE3-D7A39B29DAB1 Q36218114-61DB5F4B-0DF0-4D2B-8718-4DAA02FAE331 Q36228580-8D815C6F-BA92-4222-B550-995EE5D3B70C Q36310489-4E12361E-5246-42E7-9A51-E4E5DE4B81C9 Q36354205-CC7C98C3-F606-43B1-8220-3A988B0CD5C9 Q36627919-569ED3D6-5819-481F-B0E3-5F70FC16E50E Q36722509-38C68204-A680-4138-AA4B-D17A0694271E Q36739472-F3E7D889-501A-44E8-9327-9F3D4ECD23BC Q36814725-38BD0DFE-A632-4B79-9A88-AA2949A88845 Q37038644-5B80AC55-2111-4E12-94E9-7AAC57DCA2FD Q37090612-4367D38E-E639-493E-B47F-53867ABB04F3 Q37135393-E5102F3D-C903-445B-B85D-52C7718BA760 Q37188529-39342E0A-1C47-4EAB-9346-87F54E330AE2 Q37205804-FD2E55B3-B64C-4081-A1AB-3028E91C8754 Q37245815-6788967E-E1EA-4430-9B4D-DB730E68AB99 Q37299519-6D18A24A-962E-4E50-B421-A9C30112E9F8 Q37636132-08D4E267-09AF-46B9-A35B-EAA35D1635A4 Q37936459-A16962E7-C290-4E3B-9154-0F1F45A45126 Q38211433-444FADA0-9BEE-462E-BC02-5F75130CDB69

P2860

The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.

http://www.wikidata.org/entity/Q34286402

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The multicenter uveitis steroi ...... and baseline characteristics.

@ast

The multicenter uveitis steroi ...... and baseline characteristics.

@en

The multicenter uveitis steroi ...... and baseline characteristics.

@nl

type

label

The multicenter uveitis steroi ...... and baseline characteristics.

@ast

The multicenter uveitis steroi ...... and baseline characteristics.

@en

The multicenter uveitis steroi ...... and baseline characteristics.

@nl

prefLabel

The multicenter uveitis steroi ...... and baseline characteristics.

@ast

The multicenter uveitis steroi ...... and baseline characteristics.

@en

The multicenter uveitis steroi ...... and baseline characteristics.

@nl

P1433

Q34286402-D9C17A1B-DA50-43C2-8B85-76995754C826

P1476

Q34286402-976D09AD-D4B6-4FE8-A6AA-CD36EFF71B8A

P2093

Q34286402-1C787BA6-3614-474E-8B8C-0C82D93463E9

Q34286402-4BD0813D-364A-4FD2-ACFC-21512F1A0602

Q34286402-4DD874BC-15C9-4620-852A-6B7A9D7DDE88

Q34286402-A05D361D-D356-45C5-997A-40BE1D5F922A

Q34286402-B1781B4C-71D3-40A6-B6FD-E5A392F80A76

Q34286402-C60A68DF-A7F2-443B-BE27-6532DF44D844

P2860

Q34286402-02289585-AC85-4981-9058-F7F5E6B662A9

Q34286402-0A032855-DABE-4F2A-A5B7-91DC8BE6741A

Q34286402-0A371524-4C43-4CD7-9826-56BDF00200A3

Q34286402-0DDD6CC3-1F05-42D0-96E0-5EAD0FB6ACE1

Q34286402-0EBBF37C-A302-48D4-A63C-24EA3AD7A42C

Q34286402-180834A2-BF37-4D92-8FA6-4C8DEF717E5C

Q34286402-371170B4-D505-40CA-94E6-18C88E40BC16

Q34286402-39674224-97E8-4C80-934C-D585272544C4

Q34286402-39C13241-96DE-42D4-91AE-895D80637292

Q34286402-460F9066-3AD1-48BE-B4C7-6D7304648377

P304

Q34286402-8D5EF8A4-C4CF-4BE6-A771-400C09DD83CD

P31

Q34286402-42DA8C79-43C3-4B33-B79C-A8F72B424B3D

P356

Q34286402-AB473CD7-C258-4749-9E71-CCB13E2A3E9F

P407

Q34286402-C8A5D8BD-BB1B-4DE2-AFFF-018C72C9D813

P433

Q34286402-1A6C17E4-C63F-4986-A887-B71A8582F828

P478

Q34286402-5B18A79A-2F20-410F-B3E7-DB663623CAFC

P577

Q34286402-7747E2F4-44DB-4186-9FC6-A7259CD16340

P698

Q34286402-565EC38B-E7DD-4869-B5C1-A5F72820E99F

P921

Q34286402-5E774994-3431-4934-9DE6-5815129BAD36

Q34286402-F6E277DF-5D5A-491F-8CF1-8CB6079D0E0E

P932

Q34286402-7DACC5B8-EF44-4F7E-9E0C-9C5403483645

P356

J.AJO.2009.11.019

P1433

American Journal of Ophthalmology

P1476

The multicenter uveitis steroi ...... and baseline characteristics.

@en

P2093

Douglas A Jabs

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Sugar

http://www.w3.org/2001/XMLSchema#string

Janet T Holbrook

http://www.w3.org/2001/XMLSchema#string

John H Kempen

http://www.w3.org/2001/XMLSchema#string

Michael M Altaweel

http://www.w3.org/2001/XMLSchema#string

Multicenter Uveitis Steroid Treatment Trial Research Group

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Longitudinal data analysis for discrete and continuous outcomes

EuroQol--a new facility for the measurement of health-related quality of life

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

EuroQol: the current state of play.

A comparative review of generic quality-of-life instruments.

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

P304

550-561.e10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJO.2009.11.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20097325

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

2975449

http://www.w3.org/2001/XMLSchema#string